tiprankstipranks
Advertisement
Advertisement
Indaptus Therapeutics enters $6M securities purchase agreement with David Lazar
PremiumThe FlyIndaptus Therapeutics enters $6M securities purchase agreement with David Lazar
3M ago
Indaptus Therapeutics secures new funding and leadership shift
Premium
Company Announcements
Indaptus Therapeutics secures new funding and leadership shift
3M ago
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
Premium
The Fly
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
4M ago
Indaptus Therapeutics files $200M mixed securities shelf
PremiumThe FlyIndaptus Therapeutics files $200M mixed securities shelf
7M ago
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
Premium
The Fly
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
7M ago
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
Premium
The Fly
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
7M ago
Indaptus Therapeutics Inc trading resumes
PremiumThe FlyIndaptus Therapeutics Inc trading resumes
9M ago
Indaptus Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Indaptus Therapeutics Inc trading halted, volatility trading pause
9M ago
Indaptus Therapeutics Inc trading halted, news pending
Premium
The Fly
Indaptus Therapeutics Inc trading halted, news pending
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100